MedFirst Healthcare Services Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for MedFirst Healthcare Services.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Consumer Retailing earnings growth | 17.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Dec 2023 |
Recent future growth updates
No updates
Recent updates
Does MedFirst Healthcare Services, Inc. (GTSM:4175) Have A Place In Your Dividend Stock Portfolio?
Apr 16Does MedFirst Healthcare Services (GTSM:4175) Have A Healthy Balance Sheet?
Mar 30Should MedFirst Healthcare Services (GTSM:4175) Be Disappointed With Their 19% Profit?
Mar 12What Do The Returns On Capital At MedFirst Healthcare Services (GTSM:4175) Tell Us?
Feb 22Is MedFirst Healthcare Services, Inc.'s (GTSM:4175) 10% ROE Strong Compared To Its Industry?
Feb 02Tread With Caution Around MedFirst Healthcare Services, Inc.'s (GTSM:4175) 5.1% Dividend Yield
Jan 04Here's Why MedFirst Healthcare Services (GTSM:4175) Is Weighed Down By Its Debt Load
Dec 17The MedFirst Healthcare Services (GTSM:4175) Share Price Has Gained 22% And Shareholders Are Hoping For More
Dec 02The Returns At MedFirst Healthcare Services (GTSM:4175) Provide Us With Signs Of What's To Come
Nov 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 8,039 | 106 | 464 | 764 | 1 |
12/31/2023 | 7,446 | 47 | 572 | 795 | N/A |
9/30/2023 | 7,304 | 52 | 1,003 | 1,250 | N/A |
6/30/2023 | 7,163 | 78 | 459 | 747 | N/A |
3/31/2023 | 7,373 | 159 | 614 | 920 | N/A |
12/31/2022 | 7,224 | 171 | 778 | 1,070 | N/A |
9/30/2022 | 7,115 | 175 | 776 | 1,019 | N/A |
6/30/2022 | 7,008 | 126 | 587 | 1,028 | N/A |
3/31/2022 | 6,647 | 72 | 364 | 797 | N/A |
12/31/2021 | 6,540 | 68 | 588 | 1,000 | N/A |
9/30/2021 | 6,400 | 79 | 107 | 569 | N/A |
6/30/2021 | 6,299 | 96 | 343 | 654 | N/A |
3/31/2021 | 5,991 | 85 | 1 | 429 | N/A |
12/31/2020 | 5,927 | 110 | 88 | 553 | N/A |
9/30/2020 | 5,767 | 115 | -30 | 476 | N/A |
6/30/2020 | 5,602 | 140 | -377 | 221 | N/A |
3/31/2020 | 5,521 | 157 | -224 | 300 | N/A |
12/31/2019 | 5,305 | 141 | -314 | 174 | N/A |
9/30/2019 | 5,111 | 143 | -217 | 168 | N/A |
6/30/2019 | 4,908 | 131 | 113 | 318 | N/A |
3/31/2019 | 4,745 | 118 | 400 | 524 | N/A |
12/31/2018 | 4,633 | 113 | 257 | 330 | N/A |
9/30/2018 | 4,512 | 104 | 401 | 457 | N/A |
6/30/2018 | 4,478 | 111 | 383 | 444 | N/A |
3/31/2018 | 4,409 | 103 | 134 | 206 | N/A |
12/31/2017 | 4,324 | 91 | -327 | 190 | N/A |
9/30/2017 | 4,274 | 84 | N/A | 226 | N/A |
6/30/2017 | 4,198 | 80 | N/A | 130 | N/A |
3/31/2017 | 4,147 | 92 | N/A | 131 | N/A |
12/31/2016 | 4,110 | 102 | N/A | 336 | N/A |
9/30/2016 | 4,073 | 107 | N/A | 97 | N/A |
6/30/2016 | 4,005 | 114 | N/A | 165 | N/A |
3/31/2016 | 3,963 | 116 | N/A | 181 | N/A |
12/31/2015 | 3,880 | 122 | N/A | 144 | N/A |
9/30/2015 | 3,789 | 122 | N/A | 119 | N/A |
6/30/2015 | 3,758 | 116 | N/A | 81 | N/A |
3/31/2015 | 3,682 | 107 | N/A | 43 | N/A |
12/31/2014 | 3,607 | 98 | N/A | 84 | N/A |
9/30/2014 | 3,518 | 92 | N/A | 132 | N/A |
6/30/2014 | 3,424 | 96 | N/A | 22 | N/A |
3/31/2014 | 3,384 | 102 | N/A | 36 | N/A |
12/31/2013 | 3,366 | 105 | N/A | 68 | N/A |
9/30/2013 | 3,343 | 96 | N/A | 9 | N/A |
6/30/2013 | 3,309 | 80 | N/A | 167 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4175's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 4175's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4175's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4175's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 4175's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4175's Return on Equity is forecast to be high in 3 years time